Article

Autophagy suppresses progression of K-ras-induced lung tumors to oncocytomas and maintains lipid homeostasis

The Cancer Institute of New Jersey, New Brunswick, New Jersey 08903, USA
Genes & Development (Impact Factor: 10.8). 07/2013; 27(13):1447-61. DOI: 10.1101/gad.219642.113
Source: PubMed

ABSTRACT

Macroautophagy (autophagy hereafter) degrades and recycles proteins and organelles to support metabolism and survival in starvation. Oncogenic Ras up-regulates autophagy, and Ras-transformed cell lines require autophagy for mitochondrial function, stress survival, and engrafted tumor growth. Here, the essential autophagy gene autophagy-related-7 (atg7) was deleted concurrently with K-ras(G12D) activation in mouse models for non-small-cell lung cancer (NSCLC). atg7-deficient tumors accumulated dysfunctional mitochondria and prematurely induced p53 and proliferative arrest, which reduced tumor burden that was partly relieved by p53 deletion. atg7 loss altered tumor fate from adenomas and carcinomas to oncocytomas-rare, predominantly benign tumors characterized by the accumulation of defective mitochondria. Surprisingly, lipid accumulation occurred in atg7-deficient tumors only when p53 was deleted. atg7- and p53-deficient tumor-derived cell lines (TDCLs) had compromised starvation survival and formed lipidic cysts instead of tumors, suggesting defective utilization of lipid stores. atg7 deficiency reduced fatty acid oxidation (FAO) and increased sensitivity to FAO inhibition, indicating that with p53 loss, Ras-driven tumors require autophagy for mitochondrial function and lipid catabolism. Thus, autophagy is required for carcinoma fate, and autophagy defects may be a molecular basis for the occurrence of oncocytomas. Moreover, cancers require autophagy for distinct roles in metabolism that are oncogene- and tumor suppressor gene-specific.

Download full-text

Full-text

Available from: Wenyun Lu
  • Source
    • "The Golgi undergoes disassembly at mitosis for proper partitioning in daughter cells and in response to metabolic stress to conserve energy (Mao et al., 2013). To test if metabolic stress triggers Golgi disassembly and enhances LAMP-2 glycosylation that is alleviated by autophagy, isogenic tumor cells wild-type or null for the essential autophagy gene ATG7 (Guo et al., 2013a) were starved and Golgi and LAMP-2 localization and glycosylation were examined. Wild-type cells displayed no changes in LAMP-2 glycosylation but had increased P-AMPK, inhibition of P-S6, perinuclear Golgi with distinct LAMP-2 localization, and only modest Golgi disruption with prolonged starvation (Figures 6A and 6B). "
    [Show abstract] [Hide abstract]
    ABSTRACT: Oncocytomas are predominantly benign neoplasms possessing pathogenic mitochondrial mutations and accumulation of respiration-defective mitochondria, characteristics of unknown significance. Using exome and transcriptome sequencing, we identified two main subtypes of renal oncocytoma. Type 1 is diploid with CCND1 rearrangements, whereas type 2 is aneuploid with recurrent loss of chromosome 1, X or Y, and/or 14 and 21, which may proceed to more aggressive eosinophilic chromophobe renal cell carcinoma (ChRCC). Oncocytomas activate 5′ adenosine monophosphate-activated protein kinase (AMPK) and Tp53 (p53) and display disruption of Golgi and autophagy/lysosome trafficking, events attributed to defective mitochondrial function. This suggests that the genetic defects in mitochondria activate a metabolic checkpoint, producing autophagy impairment and mitochondrial accumulation that limit tumor progression, revealing a novel tumor-suppressive mechanism for mitochondrial inhibition with metformin. Alleviation of this metabolic checkpoint in type 2 by p53 mutations may allow progression to eosinophilic ChRCC, indicating that they represent higher risk.
    Full-text · Article · Nov 2015 · Cell Reports
    • "Of note, autophagic responses are negatively regulated by mechanistic target of rapamycin (MTOR) complex I (MTORCI), a key hub for the control of cell survival, growth and proliferation (Laplante & Sabatini, 2012). Autophagy plays a major role in the differentiation and function of adipocytes (Singh et al, 2009b; Zhang et al, 2009), in the mobilization of lipid droplets within hepatocytes (a process that has been dubbed " lipophagy " ) (Singh et al, 2009a), as well as in the oxidation of fatty acids (FAs) by cancer cells (Guo et al, 2013), underscoring its significant impact on lipid metabolism. Conversely, several saturated FAs (SFAs) and unsaturated FAs (UFAs) appear to modulate autophagy (Brenner et al, 2013). "
    [Show abstract] [Hide abstract]
    ABSTRACT: To obtain mechanistic insights into the cross talk between lipolysis and autophagy, two key metabolic responses to starvation, we screened the autophagy-inducing potential of a panel of fatty acids in human cancer cells. Both saturated and unsaturated fatty acids such as palmitate and oleate, respectively, triggered autophagy, but the underlying molecular mechanisms differed. Oleate, but not palmitate, stimulated an autophagic response that required an intact Golgi apparatus. Conversely, autophagy triggered by palmitate, but not oleate, required AMPK, PKR and JNK1 and involved the activation of the BECN1/PIK3C3 lipid kinase complex. Accordingly, the downregulation of BECN1 and PIK3C3 abolished palmitate-induced, but not oleate-induced, autophagy in human cancer cells. Moreover, Becn1+/− mice as well as yeast cells and nematodes lacking the ortholog of human BECN1 mounted an autophagic response to oleate, but not palmitate. Thus, unsaturated fatty acids induce a non-canonical, phylogenetically conserved, autophagic response that in mammalian cells relies on the Golgi apparatus.
    No preview · Article · Jan 2015 · The EMBO Journal
  • Source
    • "In contrast, loss of p53 in autophagy-competent tumors only accelerated adenocarcinoma development, and did not result in lipid droplet accumulation [47]. Cells isolated from the autophagy-deficient p53−/− tumors had high basal lipid levels, were more sensitive to starvation and could not form solid tumors in nude mice [47]. Taken together, these data indicate that autophagy promotes NSCLC, especially under metabolic stress, caused by the loss of p53. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Autophagy, a process of self-degradation and turnover of cellular components, plays a complex role in cancer. Evidence exists to show that autophagy may support tumor growth and cell survival, whereas it can also contribute to tumor suppression and have anti-survival characteristics in different cellular systems. Numerous studies have described the effects of various oncogenes and tumor suppressors on autophagy. The small GTPase Ras is an oncogene involved in the regulation of various cell-signaling pathways, and is mutated in 33% of human cancers. In the present review, we discuss the interplay between Ras and autophagy in relation to oncogenesis. It appears that Ras can upregulate or downregulate autophagy through several signaling pathways. In turn, autophagy can affect the tumorigenicity driven by Ras, resulting in either tumor progression or repression, depending on the cellular context. Furthermore, Ras inhibitors were shown to induce autophagy in several cancer cell lines.
    Full-text · Article · Feb 2014 · Oncotarget
Show more